DTIL Insider Trading Activity and SEC Form 4 Filings
DTIL insider trading summary
Over the past 12 months, insiders at Precision Biosciences Inc (DTIL) reported 8 sales worth $431K by 4 insiders and 6 open-market purchases worth $63K by 3 insiders on SEC Form 4. Net insider selling was $368K.
Latest DTIL insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Sep 28, 2026 | Stanley Frankel | Director | Buy | $6K (1,000 @ $6.00) |
| Sep 25, 2026 | Melinda Brown | Director | Buy | $7K (1,135 @ $6.27) |
| Sep 25, 2026 | Geno J Germano | Director | Buy | $16K (2,609 @ $6.28) |
| Feb 18, 2026 | John Alexander Kelly | Chief Financial Officer | Sell | $31K (8,149 @ $3.84) |
| Feb 18, 2026 | Dario Scimeca | General Counsel and Secretary | Sell | $19K (4,925 @ $3.84) |
| Feb 18, 2026 | Michael Amoroso | President and CEO | Sell | $79K (20,559 @ $3.84) |
| Feb 18, 2026 | J. Jefferson Smith | Chief Research Officer | Sell | $19K (4,925 @ $3.84) |
| Jan 22, 2026 | Michael Amoroso | President and CEO | Sell | $145K (34,799 @ $4.17) |
| Jan 21, 2026 | Dario Scimeca | General Counsel and Secretary | Sell | $36K (8,854 @ $4.03) |
| Jan 21, 2026 | John Alexander Kelly | Chief Financial Officer | Sell | $61K (15,213 @ $4.03) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.